Skip to main content
. 2024 Sep 9;11(3):341–351. doi: 10.3934/Neuroscience.2024021

Table 3. Clinical scores and Effect Sizes for Efficacy Measures in Patients Receiving NFB at Baseline and Week 2.

Baseline (T0)
Week 2 (T1)
Wilcoxon Test
p
Cohen's d
d
PANSS Mean SD Mean SD
 Positive 8.33 1.32 8.00 1.50 .83 .20
 Negative 9.33 1.80 8.67 1.80 .83 .40
 General Psychopatology 21.00 3.77 19.33 3.04 .83 .40
 Total score 38.67 6.56 36.00 6.24 .83 .40